| Today's Open | $78.72 |
|---|---|
| Previous Close | $77.89 |
| Daily Range | $77.69 - $79.54 |
| 52-Week Range | $38.44 - $87.47 |
| Market Cap | $17.6B |
| P/E Ratio | -33.00 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 2,622,604 |
| Average Daily Volume | 3,385,927 |
| Current FY EPS | -$2.13 |
Sector
Healthcare
Industry
Drugs
Vertex Pharmaceuticals (VRTX) Description
The Company is in the business of discovering, developing and commercializing small molecule drugs for the treatment of serious diseases. Website: http://www.vrtx.com/
News & Commentary
2 Scariest Dividend Stocks in Health Care
The yields look great, but these 2 health-care dividend stocks could be the scariest ones around in the near future.Racing Toward the Next Hepatitis C Drug Approval
Johnson & Johnson jumps ahead of Gilead Sciences in the race to bring next-generation hepatitis C drugs to market.3 Investment Strategy Lessons From Vertex's Success
Can you develop an investment strategy based on a biotech success story? Here are 3 lessons that show how it can be done.
Why AbbVie's Food and Drug Administration breakthrough designation isn't a big deal.
VRTX's Top Competitors
(2.05%)
(0.63%)
(2.44%)
(-0.50%)